# QT Imaging Holdings, Inc

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/fi/companies/QT Imaging Holdings, Inc).

## Overview

QT Imaging Holdings, Inc. develops and commercializes the QT Breast Scanner, a breast imaging system used in medical settings for screening and diagnostic workflows. The company is based in the United States and operates through a mix of direct sales and distribution partners, with products, software, accessories, and related services tied to its imaging platform.

## Products & services

• QT Breast Scanner imaging system
• Associated software and cloud SaaS subscriptions
• Accessories and scanner-related consumables
• Training services for clinical users
• Maintenance and servicing of installed systems

- **Breast imaging systems** (70%) — QT Breast Scanner hardware used for breast imaging and screening workflows.
- **Software and cloud subscriptions** (10%) — Software and cloud-based platform access tied to scanner operation and use.
- **Accessories and related products** (10%) — Scanner accessories and other product add-ons sold with the imaging system.
- **Training services** (5%) — Customer training for operators and clinical staff using the QT platform.
- **Maintenance and support services** (5%) — Ongoing servicing, maintenance, and related support for installed systems.

- QT Breast Scanner imaging system
- Associated software and cloud SaaS subscriptions
- Accessories and scanner-related consumables
- Training services for clinical users
- Maintenance and servicing of installed systems

## Customers

Customers are hospitals, radiology centers, clinics, and other medical providers that use breast imaging equipment in clinical workflows. The company also sells through distributors and sales agents, including exclusive arrangements in the U.S. and selected international markets, which broadens access to end users while keeping direct sales optional.

- **Hospitals** (primary) — Buy QT Breast Scanners for inpatient and outpatient breast imaging workflows.
- **Radiology centers** (primary) — Purchase scanners to expand breast imaging capacity and diagnostic offerings.
- **Clinics and medical practices** (secondary) — Use the system for breast screening and referral-based diagnostic imaging.
- **Distributors and sales agents** (primary) — Resell, lease, or rent the scanners and help reach local healthcare buyers.
- **Government and defense customers** (emerging) — Buy through designated territories such as U.S. Department of Defense sites.

- Hospitals buying breast imaging systems for clinical use
- Radiology centers seeking imaging equipment and workflow tools
- Clinics and medical practices adding breast screening capability
- Distributors and sales agents reselling into local healthcare markets
- Government and defense-related facilities in covered territories

## Geography

QT Imaging is centered on the U.S. market, where its distribution agreement covers the United States and U.S. territories, while the company retains the ability to sell elsewhere globally. The reports also reference planned expansion into other regions and a Saudi Arabia distribution agreement, indicating an early international commercialization footprint.

- United States is the core commercial market for scanner sales
- U.S. territories are included in the main distribution footprint
- U.S. Department of Defense installations are covered in sales territories
- International sales are possible through direct sales or partners
- Saudi Arabia is an identified early overseas distribution market

## Strategy

The company’s strategy is to commercialize the QT Breast Scanner through product innovation, clinical adoption, and partner-led distribution. It also emphasizes internal manufacturing capability and strategic manufacturing partnerships to support broader scale-up and market access.

- **Drive clinical adoption of the QT Breast Scanner** (short-term) — The business depends on hospitals and radiology centers accepting a new imaging platform.
- **Expand distribution partnerships** (short-term) — Partner channels help reach buyers faster than a direct-only sales model.
- **Improve product and software capabilities** (medium-term) — Imaging quality, usability, and analytics support differentiation and repeat use.
- **Scale manufacturing and service delivery** (medium-term) — Broader commercialization requires reliable production, fulfillment, and support.

- Improve imaging performance with software, AI, and smart physics
- Expand clinical adoption in hospitals and radiology centers
- Use distributors and sales agents to accelerate market reach
- Build service and training capability around installed systems
- Balance internal manufacturing with strategic scale partners

## Risks

QT Imaging faces the risks typical of an early-stage medical device company, including limited operating history, adoption uncertainty, and the need for regulatory and clinical acceptance. Its partner-led sales model, debt obligations, and dependence on trained radiologists and suppliers add execution risk, while product, IP, and data-security issues can affect commercialization and trust.

- **Market acceptance of the QT Breast Scanner** [high] — Revenue depends on buyers adopting a new imaging platform at acceptable prices.
- **Training and workflow adoption by radiologists** [high] — Customers need trained professionals to review and use the images effectively.
- **Capital and debt repayment risk** [high] — The company must fund operations and meet debt cash obligations as they come due.
- **Dependence on distribution partners** [medium] — Sales execution relies on reseller and agent relationships that may not perform as expected.
- **Regulatory and product clearance risk** [high] — Additional FDA clearances may be needed for current and future products.
- **Intellectual property protection** [medium] — The company’s differentiation depends on protecting imaging technology and related know-how.

- Limited operating history makes execution and forecasting difficult
- Clinical adoption depends on hospitals and radiologists accepting the system
- Debt obligations and capital needs can constrain flexibility
- Distribution and supplier agreements are important to sales execution
- FDA and other regulatory approvals remain critical for product expansion

## Accounting

Revenue is recognized at a point in time for scanner and accessory sales when control transfers, while training and maintenance revenue is recognized as services are performed. Investors should also watch fair value accounting for warrant, derivative, and earnout liabilities, which can create large non-cash swings in reported earnings, as well as inventory and warranty-related estimates tied to a hardware business.

- **Revenue recognition for hardware and services** — Affects timing of reported revenue and gross margin
- **Fair value measurement of liabilities** — Can create large non-cash gains or losses in net income
- **Inventory and warranty estimates** — Affects cost of revenue and reported gross profit
- **Quarterly revenue concentration** — Can cause volatility in revenue and operating results

- Scanner sales are recognized when control transfers to the customer
- Training and maintenance revenue is recognized as services are delivered
- Warrant, derivative, and earnout liabilities are remeasured at fair value
- Inventory obsolescence and warranty costs affect cost of revenue
- Quarterly results can be volatile because of small sales volumes and valuation changes

---

*Last updated: 2026-09-24T10:47:01.482208+00:00*